Exelixis Inc
Common Name
Exelixis
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,077
Ticker
EXEL
Exchange
NASDAQ/NGS
Website
www.exelixis.comDescription
Exelixis Inc. is a biopharmaceutical company focused on developing and commercializing small-molecule therapies for cancer treatment. Established in 1994, Exelixis has carved a niche in oncology by de... Exelixis Inc. is a biopharmaceutical company focused on developing and commercializing small-molecule therapies for cancer treatment. Established in 1994, Exelixis has carved a niche in oncology by delivering highly targeted medicinal solutions. One of its cornerstone products, Cabometyx, is utilized in treating advanced renal cell carcinoma and hepatocellular carcinoma, significantly impacting the healthcare sector's approach to managing these cancers. Additionally, the company is engaged in a robust pipeline of projects aimed at diversifying its oncological therapeutic offerings. Exelixis' collaborations with other leading pharmaceutical entities enhance its research capabilities and extend its reach globally, reinforcing its role in the biopharmaceutical landscape. By focusing on unmet medical needs within the oncology sector, Exelixis plays a critical role in influencing both patient care and future therapeutic developments in cancer treatment.
Exelixis's Waste Data Preview
In 2023, Exelixis conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  | 0000000 |
Total Waste Recovered | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Hazardous Waste Generated | 0000000 | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Non-Hazardous Waste Disposed | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Limited Data Preview
You are viewing a limited preview of Exelixis’s Waste Management dataset. The full dataset, available for download, includes total waste generated, broken down by hazardous and non-hazardous streams, along with reported recovery and disposal figures with historical coverage back to undefined.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Exelixis’s Waste Management Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Exelixis’s data sources below and access millions more through our Disclosure Search.
a. Exelixis's Sustainability Report 2023
Want Full Access to Exelixis's Waste Management Dataset?
Explore Peer Companies
Ionis Pharmaceuticals Inc
Healthcare
Biotechnology
United States
Insmed Inc
Healthcare
Biotechnology
United States
Alnylam Pharmaceuticals Inc
Healthcare
Biotechnology
United States
Cytokinetics Inc
Healthcare
Biotechnology
United States
Sarepta Therapeutics Inc
Healthcare
Biotechnology
United States
Moderna Inc
Healthcare
Biotechnology
United States